Nathan B. Fountain
CIK: 0001869596
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABOS
Acumen Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
About Fountain Nathan B
Fountain Nathan B (SEC CIK 0001869596) files insider reports with the SEC as Director of Acumen Pharmaceuticals, Inc. (ABOS).
Signal8 holds 3 ownership filings by Fountain Nathan B, all Form 4s, filed between Jun 5, 2025 and Jun 10, 2026. Those filings report 3 transactions, from Jun 4, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fountain Nathan B's filings is in NEWTON, MA.
Recent filings by Fountain Nathan B
Other insiders filing for Acumen Pharmaceuticals, Inc. (ABOS)
- Porter Derrell, Director
- RA CAPITAL MANAGEMENT, L.P., Director
- Drapkin Kimberlee C, Director
- Stalfort John A III, Director
- Ives Jeffrey L., Director
- Golumbeski George, Director